Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A cadre of older patients with cystic fibrosis have defied the life expectancy associated with their illness. They’re inspiring and educating others about surviving with the disease long-term.
For the inaugural Spinoff Prize, Nature sought out the most exciting science-based companies to have emerged from academic labs in the past three years. Here are the selected firms: 12 finalists, and 32 ‘ones to watch’.
A firm that combines single-cell analysis and neural networks to identify biomarkers for rare diseases has made it on to the shortlist for The Spinoff Prize.
RNA is now known to travel outside cells to tissues around the body. Researchers are working out whether they can exploit this extracellular RNA to detect and treat disease.